A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy

British Journal of Cancer

Volumn 107, Issue 4, 2012, Pages 748-753

  Talbot, C J ^a   Tanteles, G A ^a,b   Barnett, G C ^c,d   Burnet, N G ^c   Chang Claude, J ^e   Coles, C E ^c   Davidson, S ^f   Dunning, A M ^d   Mills, J ^b   Murray, R J S ^a   Popanda, O ^e   Seibold, P ^e   West, C M L ^g   Yarnold, J R ^h   Symonds, R P ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f CHRISTIE HOSPITAL   (United Kingdom)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

breast cancer; genetics; normal tissue radiation injury; tumour necrosis factor alpha (TNF )

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; DNA REPAIR; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; SINGLE NUCLEOTIDE POLYMORPHISM; TELANGIECTASIA;

BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIATION INJURIES; RADIOTHERAPY; RISK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864868856     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.290     Document Type: Article

References (25)

1. Andreassen CN, Alsner J (2009) Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. Radiother Oncol 92: 299-309
2. Barnett GC, Coles CE, Elliott RM, Baynes C, Luccarini C, Conroy D, Wilkinson JS, Tyrer J, Misra V, Platte R, Gulliford SL, Sydes MR, Hall E, Bentzen SM, Dearnaley DP, Burnet NG, Pharoah PD, Dunning AM, West CM (2011a) Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. Lancet Oncol 13(1): 65-77
3. Barnett GC, West CM, Coles CE, Pharoah PD, Talbot CJ, Elliott RM, Tanteles GA, Symonds RP, Wilkinson JS, Dunning AM, Burnet NG, Bentzen SM (2011b) Standardized total average toxicity score: a scaleand grade-independent measure of late radiotherapy toxicity to Facilitate pooling of data from different studies. Int J Radiat Oncol Biol Phys 82(3): 1065-1074
4. Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE, Pharoah PD, Burnet NG (2009a) Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 9: 134-142
5. Barnett GC, Wilkinson J, Moody AM, Wilson CB, Sharma R, Klager S, Hoole AC, Twyman N, Burnet NG, Coles CE (2009b) A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results. Radiother Oncol 92: 34-41
6. Barnett GC, Wilkinson JS, Moody AM, Wilson CB, Twyman N, Wishart GC, Burnet NG, Coles CE (2011) Randomized controlled trial of forwardplanned intensity-modulated radiotherapy for early breast cancer: interim results at 2 years. Int J Radiat Oncol Biol Phys 82(2): 715-723
7. Bentzen SM, Dorr W, Anscher MS, Denham JW, Hauer-Jensen M, Marks LB, Williams J (2003) Normal tissue effects: reporting and analysis. Semin Radiat Oncol 13(3): 189-202
8. Coles C, Yarnold J, Trials IMPORT, Management Group (2006) The IMPORT trials are launched (September 2006). Clin Oncol (R Coll Radiol) 18: 587-590
9. Curwen GB, Cadwell KK, Winther JF, Tawn EJ, Rees GS, Olsen JH, Rechnitzer C, Schroeder H, Guldberg P, Cordell HJ, Boice Jr JD (2010) The heritability of G2 chromosomal radiosensitivity and its association with cancer in Danish cancer survivors and their offspring. Int J Radiat Biol 86: 986-995
10. Donovan E, Bleakley N, Denholm E, Evans P, Gothard L, Hanson J, Peckitt C, Reise S, Ross G, Sharp G, Symonds-Tayler R, Tait D, Yarnold J, Breast Technology Group (2007) Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 82: 254-264
11. Finnon P, Robertson N, Dziwura S, Raffy C, Zhang W, Ainsbury L, Kaprio J, Badie C, Bouffler S (2008) Evidence for significant heritability of apoptotic and cell cycle responses to ionising radiation. Hum Genet 123: 485-493
12. Flesch-Janys D, Slanger T, Mutschelknauss E, Kropp S, Obi N, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Berger J, Chang-Claude J (2008) Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer 123: 933-941
13. Giotopoulos G, Armstrong C, Osman A, Peat I, Symonds RP, Talbot CJ (2008) Refining the evidence for GSTA1 and eNOS genetic effects on risk of radiotherapy-induced telangiectasia. Int J Cancer 123: 2973-2974
14. Giotopoulos G, Symonds RP, Foweraker K, Griffin M, Peat I, Osman A, Plumb M (2007) The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer 96: 1001-1007
15. Kerns SL, Ostrer H, Stock R, Li W, Moore J, Pearlman A, Campbell C, Shao Y, Stone N, Kusnetz L, Rosenstein BS (2010) Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 78: 1292-1300
16. Lilla C, Ambrosone CB, Kropp S, Helmbold I, Schmezer P, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Chang-Claude J (2007) Predictive factors for late normal tissue complications following radiotherapy for breast cancer. Breast Cancer Res Treat 106: 143-150
17. Martin S, Sydenham M, Haviland J, A'Hern R, Owen R, Bliss J, Yarnold J (2010) Test of association between variant tgbeta1 alleles and late adverse effects of breast radiotherapy. Radiother Oncol 97: 15-18
18. Mekinian A, Tamouza R, Pavy S, Gestermann N, Ittah M, Mariette X, Miceli-Richard C (2011) Functional study of TNF-alpha promoter polymorphisms: literature review and meta-analysis. Eur Cytokine Netw 22: 88-102
19. Murray RJ, Tanteles GA, Mills J, Perry A, Peat I, Osman A, Chan S, Cheung KL, Chakraborti PR, Woodings PL, Barwell JG, Symonds RP, Talbot CJ (2011) Association between single nucleotide polymorphisms in the DNA repair gene LIG3 and acute adverse skin reactions following radiotherapy. Radiother Oncol 99: 231-234
20. O'Sullivan B, Levin W (2003) Late radiation-related fibrosis: pathogenesis, manifestations, and current management. Semin Radiat Oncol 13: 274-289
21. Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, Jia X, Alfredsson L, Padyukov L, Klareskog L, Worthington J, Siminovitch KA, Bae SC, Plenge RM, Gregersen PK, de Bakker PI (2012) Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 44: 291-296
22. Smirnov DA, Morley M, Shin E, Spielman RS, Cheung VG (2009) Genetic analysis of radiation-induced changes in human gene expression. Nature 459: 587-591
23. Sullivan DE, Ferris M, Nguyen H, Abboud E, Brody AR (2009) TNF-alpha induces TGF-beta1 expression in lung fibroblasts at the transcriptional level via AP-1 activation. J Cell Mol Med 13: 1866-1876
24. Tanteles GA, Whitworth J, Mills J, Peat I, Osman A, McCann GP, Chan S, Barwell JG, Talbot CJ, Symonds RP (2009) Can cutaneous telangiectasiae as late normal-tissue injury predict cardiovascular disease in women receiving radiotherapy for breast cancer? Br J Cancer 101: 403-409
25. Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J, Haviland J, Bentzen S, Owen R (2005) Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 75: 9-17